5-MeO-2,N,N-TMT

From Wikipedia, the free encyclopedia

5-MeO-2,N,N-TMT
Systematic (IUPAC) name
2-(5-methoxy-2-methyl-H-indol-3-yl)-N,N-dimethylethanamine
Identifiers
CAS number 67292-68-6
ATC code  ?
PubChem 49756
Chemical data
Formula C14H20N2O 
Mol. mass 232.321 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

5-MeO-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#45) [1]. It is claimed to show psychoactive effects at a dosage of 75-150mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.


[edit] References

  1. ^ Erowid Online Books : "TIHKAL" - #45 5-MEO-TMT